Company / R&D per Share
Embecta Corp. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.65
FY2025
5-year range
$0.65 / $1.49
FY2021-FY2025
Trend
-53.0%
vs FY2024
Sector context
#83 of 108
Health Care
What the data says
Embecta Corp.'s r&d per share of $0.65 is lower than 77% of companies in the Health Care sector (FY2025). R&D per Share has fluctuated over the past 6 years, ranging from $0.65 in FY2025 to $1.49 in FY2023.
Based on SEC 10-K filings.
0.65 in FY2025 with a 5-year CAGR of -9.7%.
Declined from $1.49 to $0.65 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -15.6%
- 5-Year CAGR
- -9.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 108This company $0.65 Sector average $2.07
▼
-68.8% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 53.0% year-over-year.
- Ranks #83 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | -53.0% |
| FY2024 | $1.37 | -8.0% |
| FY2023 | $1.49 | +38.8% |
| FY2022 | $1.08 | -3.1% |
| FY2021 | $1.11 | +3.1% |
| FY2020 | $1.08 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026